News & Events
The FDA recently approved use of an implanted brain device for patients with severe obsessive compulsive disorder.
The device is Medtronic’s Reclaim deep-brain stimulation (DBS) device. It will be used as a last-resort therapy to treat patients who have failed multiple different therapies for OCD.
Some people visit their doctor at the first sign of a physical symptom; others may wait till the symptoms interfere with their daily routine. Then there are a group of sufferers who seldom avail themselves of professional help, even when the problem negatively affects their life and the lives of their family. This last group can be characterized as “recovery avoiders,” or RA’s. Recovery avoidance is difficult for most people to understand and there are few resources available to help understand it.
